<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kaur N</submitter><funding>DBT/Wellcome Trust India Alliance</funding><funding>National Institutes of Health</funding><funding>Wellcome Trust</funding><funding>NIH HHS</funding><pagination>e63914</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7617591</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>197(3)</volume><pubmed_abstract>Several genetic disorders are associated with either a permanent deficit or a delay in central nervous system myelination. We investigated 24 unrelated families (25 individuals) with deficient myelination after clinical and radiological evaluation. A combinatorial approach of targeting and/or genomic testing was employed. Molecular diagnosis was achieved in 22 out of 24 families (92%). Four families (4/9, 44%) were diagnosed with targeted testing and 18 families (18/23, 78%) were diagnosed using broad genomic testing. Overall, 14 monogenic disorders were identified. Twenty disease-causing variants were identified in 14 genes including PLP1, GJC2, POLR1C, TUBB4A, UFM1, NKX6-2, DEGS1, RNASEH2C, HEXA, ATP7A, SETBP1, GRIN2B, OCLN, and ZBTB18. Among these, nine (45%) variants are novel. Fourtee</pubmed_abstract><journal>American journal of medical genetics. Part A</journal><pubmed_title>Neuroimaging to Genotype: Delineating the Spectrum of Disorders With Deficient Myelination in the Indian Population.</pubmed_title><pmcid>PMC7617591</pmcid><funding_grant_id>IA/CRC/20/1/600002</funding_grant_id><pubmed_authors>Kulkarni R</pubmed_authors><pubmed_authors>Narayanan DL</pubmed_authors><pubmed_authors>Sharma S</pubmed_authors><pubmed_authors>Siddiqui S</pubmed_authors><pubmed_authors>Naik R</pubmed_authors><pubmed_authors>Bielas S</pubmed_authors><pubmed_authors>Nair KV</pubmed_authors><pubmed_authors>Shukla A</pubmed_authors><pubmed_authors>Kaur N</pubmed_authors><pubmed_authors>Bhat V</pubmed_authors><pubmed_authors>Girisha KM</pubmed_authors><pubmed_authors>Nayak SS</pubmed_authors><pubmed_authors>Prasannakumar AP</pubmed_authors><pubmed_authors>Mascarenhas S</pubmed_authors><pubmed_authors>Rao LP</pubmed_authors><pubmed_authors>Yatheesha BL</pubmed_authors><pubmed_authors>Patil SJ</pubmed_authors><pubmed_authors>Majethia P</pubmed_authors><pubmed_authors>Hunakunti B</pubmed_authors><pubmed_authors>do Rosario MC</pubmed_authors><pubmed_authors>Nampoothiri S</pubmed_authors><pubmed_authors>Ramesh Bhat Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neuroimaging to Genotype: Delineating the Spectrum of Disorders With Deficient Myelination in the Indian Population.</name><description>Several genetic disorders are associated with either a permanent deficit or a delay in central nervous system myelination. We investigated 24 unrelated families (25 individuals) with deficient myelination after clinical and radiological evaluation. A combinatorial approach of targeting and/or genomic testing was employed. Molecular diagnosis was achieved in 22 out of 24 families (92%). Four families (4/9, 44%) were diagnosed with targeted testing and 18 families (18/23, 78%) were diagnosed using broad genomic testing. Overall, 14 monogenic disorders were identified. Twenty disease-causing variants were identified in 14 genes including PLP1, GJC2, POLR1C, TUBB4A, UFM1, NKX6-2, DEGS1, RNASEH2C, HEXA, ATP7A, SETBP1, GRIN2B, OCLN, and ZBTB18. Among these, nine (45%) variants are novel. Fourtee</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-05-22T03:09:01.971Z</modification><creation>2025-07-12T03:04:38.491Z</creation></dates><accession>S-EPMC7617591</accession><cross_references><pubmed>39470296</pubmed><doi>10.1002/ajmg.a.63914</doi></cross_references></HashMap>